A form of ultrasound imaging called shear-wave elastography (SWE) is more sensitive for assessing changes in skin stiffness…
Margarida Azevedo, MSc
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Azevedo, MSc
Cell therapy company Cytori Therapeutics recently announced the presentation of an update on the clinical trials SCLERADEC I and II,…
Large Scleroderma Study Offers Genetic Map, Identifies Patients at Risk for Pulmonary Hypertension
A research team with scientists from the University of Granada in Spain and the Spanish National Research Council…
In a new article, a multidisciplinary team of international researchers summarized key points and deliberations regarding basic, clinical, and novel therapeutic…
The organizing committee of the 4th Systemic Sclerosis World Congress recently held in Lisbon, Portugal on Feb. 18-20 recognized Inventiva,…
Researchers at Germany’s University of Luebeck and Charité University recently presented a study where they reported that circulating antibodies against…
Leading Researcher: Fibrosis Improved in Systemic Sclerosis and IPF Models With Monoclonal Antibody
Researchers at ChemomAb and Meir Medical Center in Tel Aviv, Israel, and the University of Florence, Italy, recently presented a…
Researchers at Paris Descartes University, France, recently presented the results of a study investigating the effects of estrogen in the…
Scientists from the University of Florence, Italy, presented a study investigating the participation of the Endothelial-to-Mesenchymal transition (EndoMT) process…
Cytori Therapeutics recently announced its participation in the 4th World Systemic Sclerosis World Congress taking place Feb. 18-20, 2016, in…